California Encephalitis Workup
- Author: Folusakin O Ayoade, MD; Chief Editor: Burke A Cunha, MD more...
The diagnosis of California encephalitis is based on immunology, because the virus is not present in blood or secretions during clinical CNS disease. The diagnosis can be established as follows:
Specific immunoglobulin M (IgM) and neutralizing antibodies to the virus in serum or cerebrospinal fluid (CSF) using enzyme-linked immunosorbent assay (ELISA) technique: IgM is usually but not always present during acute illness.
A 4-fold increase in the antivirus antibody titer between the acute and the convalescent periods, although this may not be observed in every case 
In fatal cases, nucleic acid amplification, histopathology with immunohistochemistry and virus culture of autopsy tissues can also be useful. Only a few state laboratories or other specialized laboratories, including those at the Centers for Disease Control and Prevention (CDC), are capable of performing this specialized testing.
Significant antibody titers include levels of more than 320 by hemagglutination inhibition, more than 128 by complement fixation, more than 256 by immunofluorescence, or more than 160 by plaque reduction neutralization test.
A licensed indirect fluorescent antibody test is available for IgG and IgM antibodies to La Crosse virus and may be useful in diagnosis.
In general, the findings are nonspecific and similar to other presentations of viral meningoencephalitis.
CSF examination may reveal the following:
Normal to mildly elevated pressure level
Normal glucose level and normal to mildly elevated protein level
Initially, a polymorphonuclear leukocytic pleocytosis followed by lymphocytic or monocytic leukocytosis is present.
Complete blood count and chemistry
The complete blood count (CBC) is usually within the reference range or might show mild leukocytosis. Peripheral leukocytosis in excess of 15,000 WBCs/µL is not uncommon. Chemistry findings are usually within the reference range, but hyponatremia (low serum sodium level) has been observed in up to 20% of patients in at least one case series.
Polymerase chain reaction
Use of the polymerase chain reaction for the diagnosis of La Crosse encephalitis is still in the research stage.
De los Reyes and colleagues found that children with La Crosse encephalitis who have PLEDS on electroencephalograms have a higher rate of complications.
CT Scanning and MRI
Neuroimaging using conventional computed tomography (CT) scanning and magnetic resonance imaging (MRI) is not helpful in establishing the diagnosis of California encephalitis. In very severe cases, CT scanning might show nonspecific enhancement. (See the image below.)
On pathologic examination, as with all viral encephalitides, there is a widespread degeneration of single nerve cells, with neuronophagia and scattered foci of inflammatory necrosis involving the gray and white matter. The brain stem is relatively spared. Perivascular cuffing with lymphocytes and plasma cells occurs, as well as patchy infiltration of the meninges. (See the image below.)
HAMMON WM, REEVES WC. California encephalitis virus, a newly described agent. Calif Med. 1952 Nov. 77 (5):303-9. [Medline].
Watts DM, Thompson WH, Yuill TM, DeFoliart GR, Hanson RP. Overwintering of La Crosse virus in Aedes triseriatus. Am J Trop Med Hyg. 1974 Jul. 23 (4):694-700. [Medline].
McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, et al. La Crosse encephalitis in children. N Engl J Med. 2001 Mar 15. 344 (11):801-7. [Medline].
Sokol DK, Kleiman MB, Garg BP. LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. Pediatr Neurol. 2001 Nov. 25(5):413-5. [Medline].
Wurtz R, Paleologos N. La Crosse encephalitis presenting like herpes simplex encephalitis in an immunocompromised adult. Clin Infect Dis. 2000 Oct. 31(4):1113-4. [Medline].
Hubalek Z, Sebesta O, Pesko J, Betasova L, Blazejova H, Venclikova K, et al. Isolation of Tahyna Virus (California Encephalitis Group) From Anopheles hyrcanus (Diptera, Culicidae), a Mosquito Species New to, and Expanding in, Central Europe. J Med Entomol. 2014 Nov 1. 51 (6):1264-7. [Medline].
Jones TF, Erwin PC, Craig AS, Baker P, Touhey KE, Patterson LE, et al. Serological survey and active surveillance for La Crosse virus infections among children in Tennessee. Clin Infect Dis. 2000 Nov. 31 (5):1284-7. [Medline].
de los Reyes EC, McJunkin JE, Glauser TA, Tomsho M, O'Neal J. Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome. J Child Neurol. 2008 Feb. 23(2):167-72. [Medline].
McJunkin JE, Khan R, de los Reyes EC, Parsons DL, Minnich LL, Ashley RG, et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics. 1997 Feb. 99 (2):261-7. [Medline].
Conti B, Benelli G, Leonardi M, Afifi FU, Cervelli C, Profeti R, et al. Repellent effect of Salvia dorisiana, S. longifolia, and S. sclarea (Lamiaceae) essential oils against the mosquito Aedes albopictus Skuse (Diptera: Culicidae). Parasitol Res. 2012 Jul. 111(1):291-9. [Medline].